Check GMAT Club Decision Tracker for the Latest School Decision Releases https://gmatclub.com/AppTrack

 It is currently 28 May 2017, 17:15

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Events & Promotions

###### Events & Promotions in June
Open Detailed Calendar

# The new drug Prozac and the old one Elavil are about equally

Author Message
Senior Manager
Joined: 06 Jul 2006
Posts: 293
Location: SFO Bay Area
Schools: Berkeley Haas
Followers: 2

Kudos [?]: 67 [0], given: 0

The new drug Prozac and the old one Elavil are about equally [#permalink]

### Show Tags

17 Jan 2008, 10:15
00:00

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 0% (00:00) wrong based on 0 sessions

### HideShow timer Statistics

The new drug Prozac and the old one Elavil are about equally effective in treating various forms of depression, although patients on the newer drug may have slightly fewer side effects. Thus, revenue from the sale of the new drug is going to far exceed the revenue from the sale of the old drug.

All of the following statements weaken the conclusion of the argument above, EXCEPT:

(A) Elavil is also used as a powerful anti-emetic medicine.
(B) The Drug Control Authorities in six states have refused to allow the sale of Prozac till some more tests are carried out.
(C) Some side effects of Elavil are common to Prozac as well.
(D) Prozac is not recommended as an anti-depressant for diabetics and heart patients.
(E) The unit sale price of Elavil is higher than that of Prozac.

What would you pick ?

Suntaurian
_________________

-------------------------------------------------------------
When you come to the end of your rope, tie a knot and hang on.

CEO
Joined: 29 Mar 2007
Posts: 2562
Followers: 21

Kudos [?]: 453 [0], given: 0

### Show Tags

17 Jan 2008, 10:21
suntaurian wrote:
The new drug Prozac and the old one Elavil are about equally effective in treating various forms of depression, although patients on the newer drug may have slightly fewer side effects. Thus, revenue from the sale of the new drug is going to far exceed the revenue from the sale of the old drug.

All of the following statements weaken the conclusion of the argument above, EXCEPT:

(A) Elavil is also used as a powerful anti-emetic medicine.
(B) The Drug Control Authorities in six states have refused to allow the sale of Prozac till some more tests are carried out.
(C) Some side effects of Elavil are common to Prozac as well.
(D) Prozac is not recommended as an anti-depressant for diabetics and heart patients.
(E) The unit sale price of Elavil is higher than that of Prozac.

What would you pick ?

Suntaurian

Id prolly say C b/c it appears to be rather neutral.

A: reason why Elavil will be used more/
B reason why Elavil will be used more
D: again another reason
E: Im not too sure about this one, but I guess we could say the higher price leads to increased proft. OR the higher price leads to less profit and more ppl choose Prozac. So E is kinda iffy to me.

If not C then E
Director
Joined: 01 Jan 2008
Posts: 624
Followers: 5

Kudos [?]: 184 [0], given: 1

### Show Tags

17 Jan 2008, 10:51
I'm going with E. Since the new drug is cheaper and has fewer side effects, people will switch to the new drug.
Senior Manager
Joined: 06 Jul 2006
Posts: 293
Location: SFO Bay Area
Schools: Berkeley Haas
Followers: 2

Kudos [?]: 67 [0], given: 0

### Show Tags

17 Jan 2008, 10:55
Yes even the test says, its C. I had selected E myself.

I couldn't find it to be weakening, but yes its certainly neutral compared to the other choices.

Thanks,
Suntaurian
_________________

-------------------------------------------------------------
When you come to the end of your rope, tie a knot and hang on.

VP
Joined: 22 Nov 2007
Posts: 1083
Followers: 8

Kudos [?]: 567 [0], given: 0

### Show Tags

17 Jan 2008, 11:05
suntaurian wrote:
The new drug Prozac and the old one Elavil are about equally effective in treating various forms of depression, although patients on the newer drug may have slightly fewer side effects. Thus, revenue from the sale of the new drug is going to far exceed the revenue from the sale of the old drug.

All of the following statements weaken the conclusion of the argument above, EXCEPT:

(A) Elavil is also used as a powerful anti-emetic medicine.
(B) The Drug Control Authorities in six states have refused to allow the sale of Prozac till some more tests are carried out.
(C) Some side effects of Elavil are common to Prozac as well.
(D) Prozac is not recommended as an anti-depressant for diabetics and heart patients.
(E) The unit sale price of Elavil is higher than that of Prozac.

What would you pick ?

Suntaurian

I picked C at a glance because the fact that some side effects are common is totally irrelvant: we know that Prozac has fewer side effects and this is what we car for. anyway, after having answered the question, I thought E also sounded good. If Prozac costs less, then more people would buy it....anyway, we don't know if and how consumers are sensible to price. C is definetely the best answer choice.
Manager
Joined: 21 Oct 2005
Posts: 94
Followers: 1

Kudos [?]: 16 [0], given: 0

### Show Tags

17 Jan 2008, 23:06
C it is
Senior Manager
Joined: 10 Jun 2007
Posts: 345
Location: Newport, RI
Followers: 2

Kudos [?]: 41 [0], given: 0

### Show Tags

17 Jan 2008, 23:39
(A) If it is used for another purpose, the Elavil keep pace with Prozac so this weakens the arguement.
(B) If some states have refused to sell Prozac, then that weakens the arguement.
(C) Correct...If both side effects are the same but Prozac has fewer side effects then we can assume that Prozac should sell better thus strengthening the conclusion.
(D) If Prozac isn't recommended, then these patients may buy Elavil which would weaken the arguement.
(E) This neither strengthen nor weakens the conclusion because although the unit prices are different, we don't know the quantity sold and the conclusion is focusing on revenue from sales.
Director
Joined: 30 Jun 2007
Posts: 790
Followers: 1

Kudos [?]: 165 [0], given: 0

### Show Tags

17 Jan 2008, 23:57
Since this is a EXCEPT question lets rephrase the question: Following statement does not weaken the conclusion of the argument:

(A) Elavil is also used as a powerful anti-emetic medicine. [Hold it – This has no necessary correlation to the conclusion of the argument – hold it]
(B) The Drug Control Authorities in six states have refused to allow the sale of Prozac till some more tests are carried out. [This weakens the argument – Eliminate it]
(C) Some side effects of Elavil are common to Prozac as well. [Hold it – This has no direct effect on the conclusion of the argument – hold it]
(D) Prozac is not recommended as an anti-depressant for diabetics and heart patients. [This may weaken the argument as the revenues from diabetic and heart patients are missed in this case – Eliminate it]
(E) The unit sale price of Elavil is higher than that of Prozac. [This has direct effect on the conclusion, however can weaken the argument as unit price of Elavil is higher than Prozac – Eliminate it]

Struck between – A and C

One thumb rule – When we have two items compared in the argument, it is always better to select answer choices that somehow addresses the both issues].
Eliminate – A

Re: CR - Question   [#permalink] 17 Jan 2008, 23:57
Similar topics Replies Last post
Similar
Topics:
The pharmaceutical industry argues that because new drugs 9 03 Aug 2011, 21:41
One-year-olds ordinarily prefer the taste of sweet food to 16 06 May 2011, 08:02
3 One-year-olds ordinarily prefer the taste of sweet food to 11 09 May 2008, 18:55
One-year-olds ordinarily prefer the taste of sweet food to 4 24 Sep 2007, 20:19
The Pharmaceutical industry argues that because new drugs 6 01 Sep 2007, 02:14
Display posts from previous: Sort by